negative side effects of glp 1 agonists GLP-1 nausea: How to handle GLP-1s' most common effect The Impact of Glucagon-like Peptide-1

*Correspondence: Elisabet Jerlhag, [email protected] This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Adelhorst, K., Hedegaard, B., Knudsen, L

Already, these drugs have helped millions of people manage their weight and treat type 2 diabetes

Updated: As of late Nov

However, too long a delay in bringing these drugs to an employer-sponsored plan could mean a disadvantage in recruitment and retention, as well as a decline in productivity and overall health of population

Treatment With LY2409021, a Glucagon Receptor Antagonist, Increases Liver Fat in Patients With Type 2 Diabetes